Scotts Miracle-Gro Company

Scotts Miracle-Gro has just hit a fresh 52-week low, with shares recently trading around $52.29 after falling from above $56 in mid-September. For value investors, this sharp decline raises an interesting question: is the market pricing in too much bad news? The latest numbers offer both reasons for caution and reasons for interest. Third-quarter revenue increased 1% to $1.17 billion, while adjusted earnings per share rose 8% to $2.82. Management also raised its full-year adjusted earnings guidance to $4.30–$4.45 and expects $275 million of free cash flow. Net leverage improved to 3.78 times. The problem is that gross margin slipped to 31.2%, while higher freight and commodity costs remain a pressure. Heavy debt is another important risk. The recent share-price weakness appears to reflect concerns about margins, debt and the sustainability of the recovery. The dividend is attractive at $0.66 quarterly, or $2.64 annually. Importantly, the payment has remained stable through 2024, 2025 and 2026 rather than being repeatedly reduced. The potential value case is improving earnings, free cash flow, debt reduction and shareholder returns. The counterargument is leverage and uncertain margin recovery. A sustained recovery would likely require continued earnings growth and stronger cash generation. This review is for informational and educational purposes only, not financial advice.